1. Shu-Wen Lin, Yu-Hsueh Wu, Li-Jiuan Shen. Insights from the United States to Integrate Pharmacy Education with the Pharmacist Licensure Examination to Improve Pharmacy Training in Taiwan. 國家菁英 2025 Dec; 64 (18-2): 69-90.
2. Li-Yu Chen, Ling-Chiao Liao, Chin-Ju Chuang, Cheng-Ying Hsieh, Yung-Cheng Huang, Yi-Hsuan Yang, Wan-Ting Chang, Shau-Huai Fu, Feng-Jung Yang, Kai-Chieh Chang, Ding-Cheng Chan, Li-Jiuan Shen, Fei-Yuan Hsiao, Yen-Ming Huang, Chih-Cheng Hsu and Chen-Yu Wang. Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in communitydwelling older adults: subgroup analysis of a randomized controlled trial. TherapeuTic advances in drug safety 2025, Vol. 16: 1–14. DOI: 10.1177/ 20420986251401128.
3. Chia-Wen Lai, Chung-Yen Lin, Meng-Chen Tsai, Wei-Jung Chen, Chia-Chun Hsieh, Zi-Jing Lin, Li-Jiuan Shen, Ying-Lien Chen, Lee-Jene Lai, Shu-Hwa Chen, Yang-Hsin Shih. From AI to action: Antimicrobial peptides engineered by generative adversarial networks (GANs)-A novel approach to combat resistant Bacteria. Chemical Engineering Journal 519 (2025) 164905.
4. Shu-Wen Lin, Yaw-Bin Huang, Yu-Hsueh Wu, Li-Jiuan Shen. New Perspectives on Pharmacy Education and the National Pharmacist Licensure Exam in the Post-Pandemic Era. 國家菁英 2024 Dec; 62 (17-2): 23-35.
5. Weng-Foung Huang, Jerry Kai-Chun Fu, Chen-Han Chueh, Hsin-Hung Chen, Li-Jiuan Shen, Yi-Wen Tsai. Pharmaceutical procurement profits and universal health coverage: Reform to a sustainable healthcare and financing system. Journal of the Formosan Medical Association 2024 Nov; 123: S242-S250.
6. Pei-Jhih Li, Ling-Chiao Liao, Chin-Ju Chuang, Cheng-Ying Hsieh, Yung-ChengHuang, Li-Yu Chen, Yi-Hsuan Yang, Feng-Jung Yang, Kai-Chieh Chang, Li-Jiuan Shen, Fei-Yuan Hsiao, Yen-Ming Huang, Chih-Cheng Hsu, Shau-Huai Fu, Chin-Kai Chang, and Chen-Yu Wang. Low urbanization but not illiteracy was associated with poor medication adherence among elderly people in rural Taiwan. International Journal of Clinical Practice 2024; 2024, Article ID 8080712, 8 pages, https://doi.org/10.1155/2024/8080712.
7. Chih-Fen Huang; Kuan-Lin Chen; Fang-Ju Lin; Chi-Chuan Wang; Churn-Shiouh Gau; Li-Jiuan Shen*. Enhancing Taiwan’s Healthcare Sustainability: A Delphi Study on National Medicines Policy Reforms. Journal of the Formosan Medical Association 2024 Nov; 123: S169-S179.
8. Hsiu-Ting Chien, Yu-Wen Lin, Li-Jiuan Shen, Song-Chou Hsieh, Lian-Yu Lin, Yi-An Chen, Fang-Ju Lin*. Sex-Specific Associations Between Prolonged Serum Uric Acid Levels and Risk of Major Adverse Cardiovascular Events. International Journal of Cardiology Cardiovascular Risk and Prevention 2024 Jun;22:200302.
9. Yu-Wen Huang, Lin-Chieh Meng, Li-Jiuan Shen, Chih-Fen Huang, Liang-Kung Chen, Fei-Yuan Hsiao. Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: an Interrupted Time Series Analysis. International Journal of Health Policy and Management 2024; 13:8210.
10. Kuan-Lin Chen, Yen-Ming Huang, Chih-Fen Huang, Wang-Huei Sheng, YuKuei Chen, Li-Jiuan Shen* & Chi-Chuan Wang*. Impact of an integrated medication management model on the collaborative working relationship among healthcare professionals in a hospital: an explanatory mixed methods study. Journal of Interprofessional Care 2023. Published online: 23 Oct 2023. https://doi.org/10.1080/13561820.2023.2263482.
11. Kuan-Lin Chen, Chih-Fen Hunag, Wang-Huei Sheng, Yu-Kuei Chen, Chi-Chuan Wang*, Li-Jiuan Shen*. Impact of Integrated Medication Management Program on Medication Errors in a Medical Center: An Interrupted Time Series Study. BMC Health Services Research 2022; 22: 796-.
12. Chen-Yu Wang, Shau-Huai Fu, Chih-Chien Hung, Rong-Sen Yang, Jou-Wei Lin, Ho-Min Chen, Fei-Yuan Hsiao*, Li-Jiuan Shen*. Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient with Hip Fracture in Taiwan. International Journal of Health Policy and Management 2022; 11:470-8. doi: 10.34172/ijhpm.2020.169.
13. Shin-Yi Lin, Yi-Wen Chen, Hao-Cheng Kang, Yee-Jen Wu, Pin-Zi Chen, Chia-Wei Wu, Chii-Shan Lin, Fe-Lin Lin Wu, Li-Jiuan Shen, Yen-Ming Huang, Chih-Fen Huang. Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes. Postgrad Med 2021; Nov;133: 964-73.
14. Yi-Shiu Lin, Shu-Chiao Lin, Ya-Ting Hsieh, Ling-Yu Liu, Chiu-Hsin Lin, Li-Jiuan Shen, Chih-Fen Huang. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia. European Journal of Hospital Pharmacy. 19 February 2021. doi: 10.1136/ejhpharm-2020-002567.
15. Hsiu-Li Yang, Yen-Ming Huang, Fe-Lin Lin Wu, Li-Jung Huang, Li-Hua Wang, Chin-Ling Su*, Li-Jiuan Shen*. Exploration of the Public’s Perspectives of Medication Safety in Taiwan: A Cross-sectional Study. Journal of Asian Association of Schools of Pharmacy 2020; 9: 60-6.
16. Chien-Chih Wu, Shu-Ling Tsai, Pou-Jen Ku, Fe-Lin Lin Wu, Li-Jung Huang, Wan-Yun Tseng, I-Hsun Li, Ting-Ying Wang, Ming-Shyan Wang, Li-Na Kuo, Yuh-Lih Chang, Hui-Chen Su, Yu-Jing Lin, Yih-Dih Cheng, Chi-Hua Chen, Yu-Chia Huang, Chi-Chuan Wang, Li-Jiuan Shen*. Cost-benefit of reimbursement for pharmaceutical care in Taiwan. Journal of the American College of Clinical Pharmacy 2021; 4: 604-11.
17. 黃織芬 沈麗娟 朱蓁蓁 張香瑩 王麗華 郭奕靚 林慧玲. 加護病房靜脈同時給予多種藥品之型態與風險. 台灣醫學2021; 25: 180-92.
18. 蘇錦玲 楊秀琍 沈麗娟 黃莉蓉 王麗華 林慧玲. 臺灣藥事服務樣態之全國性調查. 台灣醫學2021; 25: 316-23.
19. Shin-Yi Lin, Li-Jiuan Shen, Vin-Cent Wu, Wen-Je Ko, Chien-Chih Wu, Fe-Lin Lin Wu. Pharmacokinetics and dosing of vancomycin in patients undergoing sustained low efficiency daily diafiltration (SLEDD-f): a prospective study. Journal of the Formosan Medical Association 2021, 120:737-43.
20. Chen-Yu Wang, Shau-Huai Fu, Rong-Sen Yang, Liang-Kung Cheng, Li-Jiuan Shen, Fei-Yuan Hsiao. Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: A nationwide cohort study. Bone 2020 (138); 115452. https://doi.org/10.1016/j.bone.2020.115452.
21. Yi-Hsuan Lin, Li-Jiuan Shen, Tzu-Ho Chou, Yang-hsin Shih. Synthesis, Stability, and Cytotoxicity of Novel Cerium Oxide Nanoparticles for Biomedical Applications. Journal of Cluster Science 2021, 32:405–413. https://doi.org/10.1007/s10876-020-01798-4.
22. Shu-Wen Lin, Ching-Hua Kuo, Li-Jiuan Shen, Yee-Chun Chen, Chien-Ching Hung, Fe-Lin Lin. Implementation and outcomes of the therapeutic drug monitoring program for antifungal and antiretroviral agents in a tertiary medical center in Taiwan. Journal of the American College of Clinical Pharmacy 2020, 3:905–12. https://doi.org/10.1002/jac5.1284
23. Chien-Chih Wu, Fang-Ju Lin, Shu-Wen Lin, Yunn-Fang Ho, Chih-Fen Huang, Li-Jiuan Shen, Fe-Lin Lin Wu. Clinical Pharmacy Service and Pharmacist Development Program: Model and Experience from a Medical Center in Taiwan. Journal of the American College of Clinical Pharmacy 2020; 3:959-65.
24. Po-Chuan Chiu, Houng-Chi Liou, Thai-Yen Ling, Li-Jiuan Shen. Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood-Brain Barrier. Neurotherapeutics 2020; 17:1184-96. DOI 10.1007/s13311-020-00845-2.
25. P.L. Chen, J.B. Hong, L.J. Shen, Y.T. Chen, S.J. Wang and Y.H. Liao. The efficacy and safety of topical rapamycin/calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind randomized clinical trial. British Journal of Dermatology 2020, 183, 655–63. DOI 10.1111/bjd.18949.
26. Po-Chuan Chiu, Pei-Yu Hsieh, Jyun Wei Kang, Po Hsun Chang, Li-Jiuan Shen. Study of the intracellular delivery mechanism of a pH-sensitive peptide modified with enhanced green fluorescent protein. Journal of Drug Targeting 2020, 4: 408-18. DOI: 10.1080/1061186X.2019.1669041.
27. Fong-Ci Lin, Shih-Tsung Huang, Rung-Ji Shang, Chi-Chuan Wang, Fei-Yuan Hsiao, Fang-Ju Lin, Mei-Shu Lin, Kuan-Yu Hung, Jui Wang, Li-Jiuan Shen, Feipei Lai, and Chih-Fen Huang. A Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin. JMIR Medical Informatics 2019 Jul 3;7(3):e13329. doi: 10.2196/13329.
28. Wen-Jone Chen, Yao-Chun Wen, Kathleen M. Fox, Li-Jiuan Shen, Lian-Yu Lin, Yi Qian, Zhongyun Zhao, Pratik P. Rane, Fei-Yuan Hsiao. Treatment Patterns of Lipid Lowering Therapies and Possible Statin Intolerance among Statin Users with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) or Diabetes Mellitus (DM) In Taiwan. Journal of Evaluation in Clinical Practice 2020; 26:1171–80. doi: 10.1111/jep.13286.
29. Wan-Ting Lin, Fe-Lin Lin Wu, Li-Jiuan Shen, Chin-Ling Su. Regulatory and Practical Considerations of Biosimilar Products in Taiwan. Formosa Journal of Clinical Pharmacy 27 (2) 2019; 83-90. DOI:10.6168/FJCP.201904_27(2).0001
30. Tzu-Lan Huang, Fei-Yuan Hsiao, Chih-Kang Chiang, Li-Jiuan Shen, Chih-Fen Huang. Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: a nationwide cohort study. PLOS ONE 2019; 14(5): e0215248. https://doi.org/10.1371/journal.pone.0215248
31. Ching-Yen Su, Li-Jiuan Shen, Song-Chou Hsieh, Lian-Yu Lin, Fang-Ju Lin. Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study. Mayo Clinic Proceedings 2019; 94(7): 1147-57.
32. Jia-An Hung, Fei-Yuan Hsiao, Chia-Yi Wu, Fe-Lin Lin Wu, Li-Jiuan Shen, Shu-Wen Lin. Training Program Reformation May Improve Self-efficacy of Pharmacy Student. Journal of Medical Education 2019; 23: 26-41. DOI: 10.6145/jme.201903_23(1).0002
33. Chun-Pei Lin, Yin-Lin Wang, Li-Juan Shen, Chun-Pin Lin. The dentin permeability of anti-inflammatory and antibacterial drugs: In vitro study. Journal of the Formosan Medical Association, 2018; 118:828-32. https://doi.org/10.1016/j.jfma.2018.09.009
34. Shin-Yi Lin, Sung-Chun Tang, Ching-Hua Kuo, Li-Kai Tsai, Shin-Joe Yeh, Li-Jiuan Shen, Jiann-Shing Jeng (2018, Nov). Factors affecting serum concentration of dabigatran in Asian patients with non-valvular atrial fibrillation. Journal of the Formosan Medical Association, 2019; 118: 1154-60. DOI: 10.1016/j.jfma.2018.11.013.
35. Hsien-Tsung Chiu, Li-Jiuan Shen, Yee-Chun Chen, Jung-Hsin Lin, Chi-Chuan Wang (2018, Aug). Effect of Statin Use on the Risk of Medically Attended Acute Respiratory Illness among Influenza Vaccinated Elderly Vaccine. Vaccine, 36 (41): 6133-7. MOST 103-2320-B-002-015.
36.
37. Yao‐Chun Wen, Fei‐Yuan Hsiao, Zhen‐Fang Lin, Cheng‐Chung Fang, Li‐Jiuan Shen (2018, Jun). Risk of stroke associated with use of nonsteroidal anti‐inflammatory drugs during acute respiratory infection episode. Pharmacoepidemiology & drug safety, 27(6):645-651. MOST 103-2320-B-002-015.
38.
39. Fong-Ci Lin, Chen-Yu Wang, Rung Ji Shang, Fei-Yuan Hsiao, Mei-Shu Lin, Kuan-Yu Hung, Jui Wang, Zhen-Fang Lin, Feipei Lai, Li-Jiuan Shen, Chih-Fen Huang (2018, Apr). Identifying unmet treatment needs for patients with osteoporotic fracture: feasibility study for an electronic clinical surveillance system. Journal of Medical Internet Research, 20(4): e142.
40.
41. Lin-Chau Chang, Chih-Fen Huang, Mei-Shu Lai, Li-Jiuan Shen, Fe-Lin Lin Wu, Wen-Fang Cheng. (2018, Mar). Prognostic factors in epithelial ovarian cancer: A population-based study. PloS ONE, 13(3) e0194993.
42.
43. Hung-Lin Chen, Li-Jiuan Shen, Ping-Ning Hsu, Chieh-Yu Shen, Susan A. Hall, Fei-Yuan Hsiao (2018, Jan). Cumulative burden of glucocorticoid-related adverse events in patients with systemic lupus erythematosus: Findings from a 12-year longitudinal study. , 45(1): 83-89.
44.
45. Chang JY, Wang CC, Kang HC, Shen LJ, Huang CF (2017, Oct). Cost-effectiveness of the pharmacist-assisted warfarin monitoring program at a Medical Center in Taiwan. International Journal for Quality in Health Care, 29(6): 817-825.
46.
47. Wang CY, Fu SH, Yang RS, Shen LJ, Wu FL, Hsiao FY (2017, Oct). Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013. Archives of Osteoporosis, 12(1):92.
48.
49. Chen CC, Hsiao FY, Shen LJ, Wu CC (2017, Aug). The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. Medicine, 96(34):e7883.
50.
51. Tsun-Jen Wen, Yu-Wen Wen, Chun-Ru Chien, Shao-Chin Chiang, William Wei-Yuan Hsu, Li-Jiuan Shen, Fei-Yuan Hsiao (2017, Apr). Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin’s lymphoma patients under Taiwan’s national health insurance system. Journal of Evaluation in Clinical Practice, 23(2):288-293.
52.
53. Chen-Yu Wang, Zhen-Fang Lin, Chii-Ming Lee, Yi-Wen Tsai, Ting-Ying Huang, Li-Jiuan Shen, Fei-Yuan Hsiao (2017, Mar). Concomitant Use of Calcium Channel Blockers with Dual Antiplatelet Therapy and Re-hospitalization for Acute Coronary Syndrome. Pharmacoepidemiology and Drug Safety, 26(3), 229-238.
54.
55. Yao-Chun Wen, Fei-Yuan Hsiao, K. Arnold Chan, Zhen-Fang Lin, Li-Jiuan Shen, Cheng-Chung Fang (2017, Feb). Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study. The Journal of Infectious Diseases, 215(4), 503-509. MOST 103-2320-B-002-015.
56.
57. Yin Lo, Li-Jiuan Shen, Wen-Hwei Chen, Yaa-Hui Dong, Fe-Lin Lin Wu (2016, Sep). Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: a retrospective analysis. Journal of the Formosan Medical Association , 115(9): 744-751.
58.
59. Chien-Chih Wu, Li-Jiuan Shen, Li-Feng Hsu, Wen-Je Ko, Fe-Lin Lin Wu (2016, Jul). Pharmacokinetics of Vancomycin in Adults Receiving Extracorporeal Membrane Oxygenation. Journal of the Formosan Medical Association, 115(7), 560-70.
60.
61. Zhen-Fang Lin, Chen-Yu Wang, Li-Jiuan Shen, Fei-Yuan Hsiao, Fe-Lin Lin Wu (2016, Jun). Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan. Canadian Journal of Diabetes, 40(3), 264-269.
62.
63. Wan-Tseng Hsu, Li-Jiuan Shen, Chii-Ming Lee (2016, May). Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. Journal of the Formosan Medical Association , 115(5): 335-342.
64.
65. Chia-Hui Lin, Fei-Yuan Hsiao, Yen-Bin Liu, Susan Shur-Fen Gau, Chi-Chuan Wang, Li-Jiuan Shen (2016, Apr). Antidepressants and valvular heart disease: A nested case-control study in Taiwan. Medicine, 95(14): e3172. MOST 103-2320-B-002-015.
66.
67. Tzyy-Harn Yeh, Yun-Ru Chen, Szu-Ying Chen, Wei-Chiang Shen, David Ann, Jennica Zaro, Li-Jiuan Shen (2016, Jan). Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Molecular Pharmaceutics, 13(1), 262-271.
68.
69. Shu-Chiao Lin, Chih-Fen Huang, Li-Jiuan Shen, Hsueh-Ju Wang, Chia-Yu Lin, Fe-Lin Lin Wu (2015, Dec). Formulation and Stability of an Extemporaneous 0.02% Chlorhexidine Digluconate Ophthalmic Solution. Journal of the Formosan Medical Association., 114(12), 1162-1169.
70.
71. Shin-Yi Lin, Sung-Chun Tang, Li-Kai Tsai, Shin-Joe Yeh, Li-Jiuan Shen, Fe-Lin Lin Wu, Jiann-Shing Jeng (2015, Nov). Incidence and risk factors for Acute Kidney Injury Following Mannitol Infusion in Patients with Acute Stroke: A Retrospective Cohort Study. Medicine, 94(47), e2032.
72.
73. Fe-Lin Lin Wu, Sheau-Shan Liu, Ting-Ya Yang, Ming-Fang Wen, Shu-Wen Lin, Chih-Fen Huang, Kuo-Chuan Wang, Li-Jiuan Shen (2015, Oct). A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance. Therapeutic Drug Monitoring, 37(5), 609-618.
74.
75. Hung-Lin Chen, Li-Jiuan Shen, Chih-Ping Wei, Hsin-Min Lu, and Fei-Yuan Hsiao (2015, Oct). Decision to Adopt Medical Technology under the National Health Insurance System in Taiwan: Case Study of New Molecular Targeted Drugs among Non-Small Cell Lung Cancer Patients. Journal of Evaluation in Clinical Practice, 21(5), 808-816.
76.
77. Chin-I Hsu, Fei-Yuan Hsiao, Fe-Lin Lin Wu, Li-Jiuan Shen (2015, Jul). Adherence and Medication Utilization Patterns of Fixed-dose and Free Combination of Angiotensin Receptor Blocker/Thiazide Diuretics among Newly Diagnosed Hypertensive Patients: a Population-based Cohort Study. International Journal of Clinical Practice, 69(7): 729-737.
78.
79. Chien-Chih Wu, Chih-Fen Huang, Li-Jiuan Shen, Fe-Lin Lin Wu (2015, May). Successful Elimination of Methotrexate by Continuous Veno-venous Haemofiltration in a Psoriatic Patient with Methotrexate Intoxication. Acta Dermato-Venereologica, 95(5), 626–627.
80.
81. Tan-Wei Chew, Churn-Shiouh Gau, Yu-Wen Wen, Li-Jiuan Shen, C. Daniel Mullins and Fei-Yuan Hsiao (2015, Apr). Epidemiology, Clinical Profile and Treatment Patterns of Venous Thromboembolism in Cancer Patients in Taiwan: A Population-based Study. BMC Cancer, 15: 298.
82.
83. Ajit Dhananjay Jagtap, Pei-The Chang, Jia-Rong Liu, Hsio-Chun Wang, Nagendra B. Konderkar, Li-Jiuan Shen, Hsiang-Wen Tseng, Grace Shiahuy Chen, Ji-Wang Chern (2014, Oct). Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia. European Journal of Medicine Chemistry, 85, 268-288.
84.
85. Shin-Yi Lin, Sung-Chun Tang, Li-Kai Tsai, Shin-Joe Yeh, Yu-Jen Hsiao, Yu-Wei Chen, Kai-Hsiang Chen, Baksau Yip, Li-Jiuan Shen, Fe-Lin Lin Wu, Jiann-Shing Jeng (2014, Oct). Orolingual Angioedema After Alteplase Therapy of Acute Ischaemic Stroke: Incidence and Risk of Prior Angiotensin-Converting Enzyme Inhibitors Use. European Journal of Neurology, 21(10), 1285-1291.
86.
87. Wu, Fe-Lin Lin; Yeh, Tzyy-Harn; Chen, Ying-Luen; Chiu, Yu-Chin; Cheng, Ju-Chen; Wei, Ming-Feng; Shen, Li-Jiuan* (2014, Aug). Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular Pharmaceutics, 11(8),2777-2786.
88.
89. Guan-Lin Chen, Fei-Yuan Hsiao, Yaa-Hui Dong, Li-Jiuan Shen, Fe-Lin Lin Wu (2014, Jul). Statins and the Risk of Liver Injury: A Population-based Case-control Study. Pharmacoepidemiology and Drug Safety, 23(7), 719-25.
90.
91. Shan-Erh Lin, Fe-Lin Lin Wu, Ming-Feng Wei, Li-Jiuan Shen (2014, Jul). Depletion of arginine by recombinant arginine deiminase (rADI) induces nNOS-activated neurotoxicity in neuroblastoma cells. BioMed Research International, Article ID 589424, 8 pages.
92.
93. Tzyy-Harn Yeh, Fe-Lin Lin Wu, Li-Jiuan Shen (2014, Jul). Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells. Journal of Drug Targeting, 22(6),528-535.
94.
95. Yu-Ting Liao, Shu-Chen Kuo, Yi-Tzu Lee, Chien-Pei Chen, Shu-Wen Lin, Li-Jiuan Shen, Chang-Phone Fung, Wen-Long Cho, and Te-Li Chen (2014, Jul). Sheltering effect and indirect pathogenesis of carbapenem resistant Acinetobacter baumannii in polymicrobial infection. Antimicrobial Agents and Chemotherapy, 58(7): 3983-3990.
96.
97. Yaa-Hui Dong, Chia-Hsuin Chang, Fe-Lin Lin Wu, Li-Jiuan Shen, Peter Calverley, Claes-Goran Löfdahl, Mei-Shu Lai, Donald Mahler (2014, Jun). Use of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and the Risk of Tuberculosis and Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chest, 145(6), 1286-1297.
98.
99. Fuming Qiu, Yun-Ru Chen, Xiyong Liu, Cheng-Ying Chu, Li-Jiuan Shen, Jinghong Xu, Shikha Gaur, Henry Jay Forman, Hang Zhang, Shu Zheng, Yun Yen, Jian Huang, Hsing-Jien Kung, David K. Ann (2014, Apr). Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells. Science Signaling, 7(319):ra31.
100.
101. Chen-Fang Lin, Li-Jiuan Shen, Fei-Yuan Hsiao, Churn-Shiouh Gau, Fe-Lin Lin Wu (2014, Mar). Sex Differences in the Treatment and Outcome of Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-based Study. Journal of Women’s Health, 23(3): 238-245.
102.
103. Chia-Yu Lin, Li-Jiuan Shen, Chih-Fen Huang, Hsiu-Li Yang, Ying-Jung Chen, Fe-Lin Lin Wu (2013, Jun). Beyond-Use Date of Extemporaneous Morphine Hydrochloride Oral Solution. Journal of Food and Drug Analysis, 21(2) :142-146.
104.
105. Wen-Hwei Chen, Li-Jiuan Shen, Ru-Jiun Guan, Fe-Lin Lin Wu (2013, Apr). Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center. Journal of the Formosan Medical Association, 112(4), 193-200.
106.
107. Hsin Hu, Fe-Lin Lin Wu, Fu-Chang Hu, Hui-Yuan Yang, Shu-Wen Lin, Li-Jiuan Shen (2013, Feb). Effectiveness of education programs about oral antibiotic suspensions in pediatric outpatient services. Pediatrics and Neonatology, 54(1),34-42.
108.
109. Chen-Fang Lin, Li-Jiuan Shen, Fe-Lin Lin Wu, Chyi-Huey Bai, Churn-Shiouh Gau (2012, Nov). Cardiovascular Outcomes Associated with Concomitant Use of Clopidogrel and Proton Pump Inhibitors in Patients with Acute Coronary Syndrome in Taiwan. British Journal of Clinical Pharmacology, 74(5),824-834.
110.
111. Chen-Fang Lin, Fe-Lin Lin Wu, Shu-Wen Lin, Chyi-Huey Bai, Ding-Cheng Chan, Churn-Shiouh Gau, Fei-Yuan Hsiao, Li-Jiuan Shen (2012, Oct). Age, dementia, and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the national health insurance coverage. Drugs & Aging, 29(10),819-828.
112.
113. Fe-Lin Lin Wu, Yung-Ming Chen, Tai-Shuan Lai, Li-Jiuan Shen, Yunn-Fan Ho, Yi-Ting Lee, Ming-Show Wu, Shuei-Liong Lin, Kwan-Dun Wu. (2012, Oct). Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan?. Nephron Clinical Practice, 120(4):c215-c222.
114.
115. Hsiu-Li Yang, Li-Jiuan Shen, Chih-Fen Huang, Chia-Yu Lin, Wen-Hwei Chen, Ya-Ting Hsieh, Fe-Lin Lin Wu. (2012, Mar). Are Brand-Name Drugs of Better Quality than Generics? Research at a Medical Center in Taiwan. Journal of Food and Drug Analysis, 20(1), 6-11.
116.
117. I-Lin Tsai, Hsiang-Yin Liu, Ping-Hung Kuo, Jann-Yuan Wang, Li-Jiuan Shen, Ching-Hua Kuo (2011, Oct). Quantitative determination of isoniazid in biological samples by cation-selective exhaustive injection-sweeping-micellar electrokinetic chromatography. Analytical and Bioanalytical Chemistry, 401(7): 2205-2214.
118.
119. Chen-Fang Lin, Churn-Shiouh Gau, Fe-Lin Lin Wu, Fei-Yuan Hsiao, Chyi-Huey Bai, Li-Jiuan Shen. (2011, Sep). Impact of ezetimibe co-administered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan. Clinical Therapeutics, 33(9), 1120-1131.
120.
121. Li-Jiuan Shen, Hua Chou, Chih-Fen Huang, Guann-Miaw Chou, Wing Kai Chan, Fe-Lin Lin Wu (2011, Jul). Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan. Contemporary Clinical Trials, 32(4),485-491.
122.
123. Fe-Lin Lin Wu, Yu-Fen Liang, Yuan-Chen Chang, Hao-Hsin Yo, Ming-Feng Wei, Li-Jiuan Shen (2011, Apr). RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells. Journal of Biomedical Science , 18(1): 25.
124.
125. Fe-Lin Lin Wu, Yun-Ru Chen, Marie Lin, Herng-Der Chern, Li-Jiuan Shen* (2008, Oct). Variability in the Frequency of Single Nucleotide Polymorphisms of N-acetyl Transferase 2 (NAT2) Gene among the Different Ethnic Groups in Taiwan. Journal of Food and Drug Analysis, 16(5): 15-20.
126.
127. Hao-Hsin Yu, Fe-Lin Lin Wu, Shan-Erh Lin, Li-Jiuan Shen* (2008, Oct). Recombinant arginine deiminase reduces inducible nitric oxide synthase (iNOS)-mediated neurotoxicity in a co-culture of neurons and microglia. Journal of Neuroscience Research, 86(13): 2963-2972.
128.
129. Yi-Shiu Lin, Li-Jiuan Shen, Yuun-Fan Ho, Fe-Lin Lin Wu (2008, Sep). The cost of adverse drug reaction: a case report of phenytoin hypersensitivity after re-exposure in a patient with sensitivity history. 台灣醫學, 12: 537-542.
130.
131. Li-Jiuan Shen, Fe-Lin Lin Wu, Yunn-Fang Ho, Karin C.S., Chen Lin. (2008, May). Evolution of Pharmacy Education in Taiwan. Journal of the Korean Society of Pharmaceutical Regulatory Sciences, 3 (1,2) :71-77.
132.
133. Shen LJ, Wu Lin FL (2007, Mar). Nanomedicines in renal transplant rejection – focus on Sirolimus. International Journal of Nanomedicine, 2(1): 25-32.
134.
135. Shen LJ*, Shen WC (2006, Jun). Drug Evaluation: ADI-PEG-20 --a pegylated arginine deiminase for arginine-auxotrophic cancers. Current Opinion in Molecular Therapeutics, 8(3), 240-248.
136.
137. Shen LJ, Beloussow K, Shen WC (2006, Jan). Modulation of arginine metabolic pathway as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Letters, 231(1), 30-35.
138. Shen LJ, Beloussow K, Shen WC* (2005, Jan). Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochemical Pharmacology, 69(1), 97-104.
139.
140. Kuo CL, Wang RB, Shen LJ, Lien LL, Lien EJ* (2004, Jun). G-protein coupled receptors: SAR analyses of neurotransmitters and antagonists. Journal of Clinical Pharmacy and Therapeutics, 29(3): 279-298.
141.
142. Shen LJ, Lin WC, Beloussow K, Hosoya KI, Terasaki T, Ann DK, Shen WC* (2003, Nov). Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochemical Pharmacology, 66(10), 1945-1952.
143.
144. Shen LJ, Lin WC, Beloussow K, and Shen WC* (2003, Mar). Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Letters, 191(2): 165-170.
145.
146. Wu Lin FL, Shen LJ, Yang Chun-Chi, Chen CH. (1999, Feb). Stability of Extemporaneous Suspensions of Co-trimazole. 中華藥學雜誌, 519(1): 93-102.
147.
148. Wu Lin FL, Sheu CJ, Chen WH, Shen LJ, Chen CH (1997, Jul). Practical Guide for the Administration of Antimicrobial Injections in a Teaching Hospital. Formosa Journal of Clinical Pharmacy, 5, 163-177.
149.
150. Shen LJ, Wu Lin FL. (1996, Jul). Adverse Drug Reaction: Thrombocytopenia. Continuing Medical Education, 6(4): 354 -359.
151. 96. Wu Lin FL, Yang CC, Shen LJ, Chen CY (1996, Mar). Adverse Drug Reactions in a Medical Ward. Journal of the Formosan Medical Association, 95(3), 241-246.
152.
153. Ching-Yen Su, Li-Jiuan Shen, Ying-Jung Chen（2017年10月）。Learn from the U.S. FDA's Active Surveillance System to Explore the Surveillance Plate-Form in Taiwan。臺灣臨床藥學雜誌，25(4): 275-281。
154.
155. Hseuh-Ju Wang, Hsiu-Li Yang, Shu-Chiao Lin, Fe-Lin Lin Wu, Chun-Yu Wang, Li-Jiuan Shen, Chiu-Hsin Lin（2016年11月）。The Preliminary survey and assessment of hospital pharmacy compounding medications in Taiwan。臺灣醫學，20(6), 570-578。
156.
157. 林慧玲、林淑文、何藴芳、沈麗娟（2016年01月）。六年制藥學系課程設計的理念與原則：以醫院藥學為例。台灣醫學，20(1), 33-39。
158.
159. 顧記華、沈麗娟、陳基旺、何藴芳、林慧玲（2016年01月）。臺灣六年制藥學教育的創建。台灣醫學，20(1), 27-23。
160.
161. Shin-Yi Lin, Yi-Wen Chen, Hao-Cheng Kang, Yee-Jen Wu, Chen-Chen Chu, Fe-Lin Lin Wu, Li-Jiuan Shen, Chih-Fen Huang（2015年09月）。Warfarin Dosing Algorithm: Specific INR Goal for Asian Population。Formosa Journal of Clinical Pharmacy，23(3), 189-202。
162. Shu-Chiao Lin, Hsiu-Li Yang, Yi-An Wu, Fe-Lin Lin Wu, Li-Jiuan Shen, Chun-Yu Wang, Hseuh-Ju Wang（2015年09月）。Regulations of the hospital pharmacy compounding in the United States。臺灣醫學，23(3): 181-187。
163.
164. Hsiu-Li Yang, Shu-Chiao Lin, Yi-An Wu, Fe-Lin Lin Wu, Li-Jiuan Shen, Chun-Yu Wang, Hseuh-Ju Wang（2015年06月）。Introduction of the current regulations of the hospital pharmacy compounding in European countries。Formosa Journal of Clinical Pharmacy ，23(2), 91-98。
165. 黃筱芳、陳莉卿、徐珮容、黃嗣棻、林綺珊、康皓程、沈麗娟、洪冠予（2014年09月）。病人安全與品質提升─從管理架構到專案改善。台灣醫學，18(5), 558-565。
166.
167. 黃淑慧、林淑文、沈麗娟（2013年03月）。臺灣之畢業後藥學教育。醫療品質雜誌，7(2), 19-22。
168.
169. Ru-Jiun Guan, Li-Jiuan Shen, Ying Lo, Wen-Hwei Chen.（2012年07月）。Rituximab for advanced follicular lymphoma。台灣醫學，16(4), 416-424。
170. 朱蓁蓁,沈麗娟,何藴芳,林慧玲（2009年03月）。用藥安全推動成果與展望。醫療品質雜誌，3 (2),23-27。
171.
172. Wan-Tseng Hsu, Li-Jiuan Shen, Yunn-Fang Ho, Zhao-Ming Huang, Fe-Lin Lin Wu.（2008年11月）。Analysis of the reimbursements of pharmaceutical services in health insurance contracted pharmacies in Taiwan and Japan。台灣臨床藥學雜誌，16(3): 39-55。
173.
174. Fe-Lin Lin Wu, Ching-Hua Kuo, Yee-Chun Chen, Hui-Wen Huang, Li-Jiuan Shen（2008年06月）。An investigation of therapeutic outcome of anti-tuberculosis and polymorphism of NAT2 gene in Taiwan aboriginals in Some Cities。臺灣臨床藥學雜誌，16 (2): 1-15。